Search

Your search keyword '"Dhong, Hun-Jong"' showing total 394 results
Start Over Author "Dhong, Hun-Jong"
394 results on '"Dhong, Hun-Jong"'

1. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial

Author

Ahlström Emanuelsson, Cecilia, Ardusso, Ledit, Armstrong, Michael, Bardin, Philip, Barnes, Sara, Bergna, Miguel, Betz, Christian, Beule, Achim, Blotter, James, Bronescu, Valeriu, Brown, Matthew, Carrie, Sean, Chaker, Adam, Cho, Hyung-Ju, Corriveau, Marie-Noëlle, Courville, Timothy, Cuevas, Mandy, Damask, Cecelia, DeConde, Adam, Del Carpio, Jaime, De Salvo, María, Dhong, Hun-Jong, Durham, Stephen, Edin, Anton, Ehmer Jr, Dale, Elías, Pedro, Fatakia, Adil, Franzese, Christine, Gane, Simon, García, Gabriel, Gillman, Andrew, Groeger, Moritz, Harvey, Richard, Hellgren, Johan, Higgins, Thomas, Hobson, Jonathan, Jangard, Mattias, Janjua, Arif, Kara, Naveed, Karpischenko, Sergey, Kerwin, Edward, Khanova, Fatimat, Kilty, Shaun, Kim, Chang-Hoon, Kim, Seontae, Klimek, Ludger, LaForce, Craig, Leong, Samuel, Marple, Bradley, Mårtensson, Anders, Maspero, Jorge, Massey, Neil, Matz, Jonathan, McDuffie, Chad, Mella, Corina, Miller, Steven, Mirzabekyan, Ekaterina, Moss, Jonathan, Mumneh, Nayla, Nathan, Robert, Neagos, Adriana, Olze, Heidi, Ovchinnikov, Andrey, Ow, Randall, Polyakov, Dmitriy, Radeanu, Doinel, Rhee, Chae-Seo, Rojas, Ramón, Rosenbloom, Jeffrey, Ryazantsev, Sergei, Sader, Chady, Saez Scherbovsky, Pablo, Scadding, Guy, Schlosser, Rodney, Shah-Patel, Heena, Shealy, Ronald, Siddiqi, Ayesha, Silvers, Stacey, Singh, Narinder, Sommer, Doron, Soong, Weily, Sowerby, Leigh, Spafford, Peter, Stefan, Catalin, Sterling, Richard, Svistushkin, Valeriy, Talreja, Neetu, Tarasova, Galina, Tarpay, Martha, Tolcachier, Alberto, Toll, Karin Toll, van Schaik, Carolina, Webb, Luke, Wedner, H James, Wehbe, Luis, Whan Kim, Soo, Wollenberg, Barbara, Wright, Simon, Yakusevich, Vladimir, Yañez, Anahí, Yarin, Yury, Yen, David, Yeol Kim, Hyo, Han, Joseph K, Bachert, Claus, Fokkens, Wytske, Desrosiers, Martin, Wagenmann, Martin, Lee, Stella E, Smith, Steven G, Martin, Neil, Mayer, Bhabita, Yancey, Steven W, Sousa, Ana R, Chan, Robert, and Hopkins, Claire

Published
2021
Full Text
View/download PDF

18. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial

Author

Han, Joseph K, primary, Bachert, Claus, additional, Fokkens, Wytske, additional, Desrosiers, Martin, additional, Wagenmann, Martin, additional, Lee, Stella E, additional, Smith, Steven G, additional, Martin, Neil, additional, Mayer, Bhabita, additional, Yancey, Steven W, additional, Sousa, Ana R, additional, Chan, Robert, additional, Hopkins, Claire, additional, Ahlström Emanuelsson, Cecilia, additional, Ardusso, Ledit, additional, Armstrong, Michael, additional, Bardin, Philip, additional, Barnes, Sara, additional, Bergna, Miguel, additional, Betz, Christian, additional, Beule, Achim, additional, Blotter, James, additional, Bronescu, Valeriu, additional, Brown, Matthew, additional, Carrie, Sean, additional, Chaker, Adam, additional, Cho, Hyung-Ju, additional, Corriveau, Marie-Noëlle, additional, Courville, Timothy, additional, Cuevas, Mandy, additional, Damask, Cecelia, additional, DeConde, Adam, additional, Del Carpio, Jaime, additional, De Salvo, María, additional, Dhong, Hun-Jong, additional, Durham, Stephen, additional, Edin, Anton, additional, Ehmer Jr, Dale, additional, Elías, Pedro, additional, Fatakia, Adil, additional, Franzese, Christine, additional, Gane, Simon, additional, García, Gabriel, additional, Gillman, Andrew, additional, Groeger, Moritz, additional, Harvey, Richard, additional, Hellgren, Johan, additional, Higgins, Thomas, additional, Hobson, Jonathan, additional, Jangard, Mattias, additional, Janjua, Arif, additional, Kara, Naveed, additional, Karpischenko, Sergey, additional, Kerwin, Edward, additional, Khanova, Fatimat, additional, Kilty, Shaun, additional, Kim, Chang-Hoon, additional, Kim, Seontae, additional, Klimek, Ludger, additional, LaForce, Craig, additional, Leong, Samuel, additional, Marple, Bradley, additional, Mårtensson, Anders, additional, Maspero, Jorge, additional, Massey, Neil, additional, Matz, Jonathan, additional, McDuffie, Chad, additional, Mella, Corina, additional, Miller, Steven, additional, Mirzabekyan, Ekaterina, additional, Moss, Jonathan, additional, Mumneh, Nayla, additional, Nathan, Robert, additional, Neagos, Adriana, additional, Olze, Heidi, additional, Ovchinnikov, Andrey, additional, Ow, Randall, additional, Polyakov, Dmitriy, additional, Radeanu, Doinel, additional, Rhee, Chae-Seo, additional, Rojas, Ramón, additional, Rosenbloom, Jeffrey, additional, Ryazantsev, Sergei, additional, Sader, Chady, additional, Saez Scherbovsky, Pablo, additional, Scadding, Guy, additional, Schlosser, Rodney, additional, Shah-Patel, Heena, additional, Shealy, Ronald, additional, Siddiqi, Ayesha, additional, Silvers, Stacey, additional, Singh, Narinder, additional, Sommer, Doron, additional, Soong, Weily, additional, Sowerby, Leigh, additional, Spafford, Peter, additional, Stefan, Catalin, additional, Sterling, Richard, additional, Svistushkin, Valeriy, additional, Talreja, Neetu, additional, Tarasova, Galina, additional, Tarpay, Martha, additional, Tolcachier, Alberto, additional, Toll, Karin Toll, additional, van Schaik, Carolina, additional, Webb, Luke, additional, Wedner, H James, additional, Wehbe, Luis, additional, Whan Kim, Soo, additional, Wollenberg, Barbara, additional, Wright, Simon, additional, Yakusevich, Vladimir, additional, Yañez, Anahí, additional, Yarin, Yury, additional, Yen, David, additional, and Yeol Kim, Hyo, additional

Published
2021
Full Text
View/download PDF

27. Age‐associated changes in chronic rhinosinusitis endotypes

Author

Ryu, Gwanghui, primary, Dhong, Hun‐Jong, additional, Park, Minsu, additional, Hwang, Na Young, additional, Kim, Dong‐Kyu, additional, Kim, Hyo Yeol, additional, Chung, Seung‐Kyu, additional, Rhee, Chae‐Seo, additional, Cho, Seong‐Ho, additional, Hong, Sang Duk, additional, and Kim, Dae Woo, additional

Published
2020
Full Text
View/download PDF

39. Immunological Characteristics in Refractory Chronic Rhinosinusitis with Nasal Polyps Undergoing Revision Surgeries

Author

Ryu, Gwanghui, primary, Kim, Dong-Kyu, additional, Dhong, Hun-Jong, additional, Eun, Kyoung Mi, additional, Lee, Kyung Eun, additional, Kong, Il Gyu, additional, Kim, HyoYeol, additional, Chung, Seung-Kyu, additional, Kim, Dong-Young, additional, Rhee, Chae-Seo, additional, Cho, Seong-Ho, additional, Hong, Sang Duk, additional, and Kim, Dae Woo, additional

Published
2019
Full Text
View/download PDF

40. Quality of life after extended versus transsellar endoscopic skull base surgery from 767 patients.

Author

Seo, Min Young, Nam, Do‐Hyun, Kong, Doo‐Sik, Lee, Jung Joo, Ryu, Gwanghui, Kim, Hyo Yeol, Dhong, Hun‐Jong, Chung, Seung‐Kyu, Lee, Kyung Eun, Hong, Sang Duk, Nam, Do-Hyun, Kong, Doo-Sik, Dhong, Hun-Jong, and Chung, Seung-Kyu

Abstract

Objectives/hypothesis: The aim of this study was to compare sinonasal-related quality of life (QOL) in patients treated by extended or transsellar endoscopic skull base surgery.Study Design: Prospective data analysis.Methods: Prospectively collected data from patients who underwent endoscopic skull base surgery between 2012 and 2017 were analyzed. Primary outcomes were preoperative Sino-Nasal Outcome Test-20 (SNOT-20) scores and then 1-month, 3-month, and 6-month follow-up. Comparative analysis was performed between the endoscopic transsellar approach (ETA) group (n = 647) and an extended endoscopic endonasal approach (EEEA) group (n = 120). In ETA group, the SNOT-20 score was compared between patients with a nasoseptal flap (NSF) (ETA-NSF) and without an NSF (ETA-no NSF).Results: The mean total SNOT-20 score was significantly worse in the EEEA than ETA group at 1, 3, and 6 months postoperatively (P < .05). Although there was no significant difference in total SNOT-20 score between the ETA-NSF and ETA-no NSF group at 3 and 6 months after surgery, the percentage of patients with significant change (≥0.8) in the SNOT-20 score was higher in the NSF used group at 1, 3, and 6 months postoperatively (22.92% vs. 13.51%, P = .029; 20.59% vs. 5.59%, P = .039; and 24.00% vs. 4.03%, P = .003, respectively). According to multivariate analysis conducted regarding factors that deteriorate sinonasal QOL at 6 months following surgery, only NSF usage is significantly associated with poor outcome (odds ratio: 4.371, P = .011) CONCLUSIONS: Sinonasal-related QOL was significantly worse in patients treated by the EEEA versus ETA. Use of an NSF is the only poor prognostic factor in sinonasal QOL after endoscopic skull base surgery.Level Of Evidence: 2b Laryngoscope, 129:1318-1324, 2019. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results